vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and IMAX CORP (IMAX). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $125.2M, roughly 1.3× IMAX CORP). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 35.1%). Over the past eight quarters, IMAX CORP's revenue compounded faster (25.8% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
ESPR vs IMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $125.2M |
| Net Profit | — | $637.0K |
| Gross Margin | — | 57.6% |
| Operating Margin | 50.6% | 19.3% |
| Net Margin | — | 0.5% |
| Revenue YoY | 143.7% | 35.1% |
| Net Profit YoY | — | -88.0% |
| EPS (diluted) | $0.32 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $125.2M | ||
| Q3 25 | $87.3M | $106.7M | ||
| Q2 25 | $82.4M | $91.7M | ||
| Q1 25 | $65.0M | $86.7M | ||
| Q4 24 | $69.1M | $92.7M | ||
| Q3 24 | $51.6M | $91.5M | ||
| Q2 24 | $73.8M | $89.0M | ||
| Q1 24 | $137.7M | $79.1M |
| Q4 25 | — | $637.0K | ||
| Q3 25 | $-31.3M | $20.7M | ||
| Q2 25 | $-12.7M | $11.3M | ||
| Q1 25 | $-40.5M | $2.3M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | $-29.5M | $13.9M | ||
| Q2 24 | $-61.9M | $3.6M | ||
| Q1 24 | $61.0M | $3.3M |
| Q4 25 | — | 57.6% | ||
| Q3 25 | — | 63.1% | ||
| Q2 25 | — | 58.5% | ||
| Q1 25 | — | 61.4% | ||
| Q4 24 | — | 52.2% | ||
| Q3 24 | — | 55.8% | ||
| Q2 24 | — | 49.4% | ||
| Q1 24 | — | 59.3% |
| Q4 25 | 50.6% | 19.3% | ||
| Q3 25 | -11.4% | 27.2% | ||
| Q2 25 | 8.6% | 15.6% | ||
| Q1 25 | -34.0% | 19.3% | ||
| Q4 24 | -6.4% | 10.3% | ||
| Q3 24 | -31.0% | 21.2% | ||
| Q2 24 | 3.5% | 3.2% | ||
| Q1 24 | 52.5% | 15.3% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | -35.9% | 19.4% | ||
| Q2 25 | -15.4% | 12.3% | ||
| Q1 25 | -62.2% | 2.7% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | -57.2% | 15.2% | ||
| Q2 24 | -83.9% | 4.0% | ||
| Q1 24 | 44.3% | 4.1% |
| Q4 25 | $0.32 | $0.02 | ||
| Q3 25 | $-0.16 | $0.37 | ||
| Q2 25 | $-0.06 | $0.20 | ||
| Q1 25 | $-0.21 | $0.04 | ||
| Q4 24 | $-0.14 | $0.09 | ||
| Q3 24 | $-0.15 | $0.26 | ||
| Q2 24 | $-0.33 | $0.07 | ||
| Q1 24 | $0.34 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $151.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $337.9M |
| Total Assets | $465.9M | $894.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $151.2M | ||
| Q3 25 | $92.4M | $143.1M | ||
| Q2 25 | $86.1M | $109.3M | ||
| Q1 25 | $114.6M | $97.1M | ||
| Q4 24 | $144.8M | $100.6M | ||
| Q3 24 | $144.7M | $104.5M | ||
| Q2 24 | $189.3M | $91.6M | ||
| Q1 24 | $226.6M | $81.0M |
| Q4 25 | $-302.0M | $337.9M | ||
| Q3 25 | $-451.4M | $349.5M | ||
| Q2 25 | $-433.5M | $320.4M | ||
| Q1 25 | $-426.2M | $299.5M | ||
| Q4 24 | $-388.7M | $299.5M | ||
| Q3 24 | $-370.2M | $289.4M | ||
| Q2 24 | $-344.2M | $267.2M | ||
| Q1 24 | $-294.3M | $258.8M |
| Q4 25 | $465.9M | $894.0M | ||
| Q3 25 | $364.0M | $889.6M | ||
| Q2 25 | $347.1M | $868.6M | ||
| Q1 25 | $324.0M | $848.3M | ||
| Q4 24 | $343.8M | $830.4M | ||
| Q3 24 | $314.1M | $847.6M | ||
| Q2 24 | $352.3M | $827.4M | ||
| Q1 24 | $373.1M | $824.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $29.4M |
| Free Cash FlowOCF − Capex | — | $28.0M |
| FCF MarginFCF / Revenue | — | 22.3% |
| Capex IntensityCapex / Revenue | 0.0% | 1.1% |
| Cash ConversionOCF / Net Profit | — | 46.11× |
| TTM Free Cash FlowTrailing 4 quarters | — | $118.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $29.4M | ||
| Q3 25 | $-4.3M | $67.5M | ||
| Q2 25 | $-31.4M | $23.2M | ||
| Q1 25 | $-22.6M | $7.0M | ||
| Q4 24 | $-35.0M | $11.5M | ||
| Q3 24 | $-35.3M | $35.3M | ||
| Q2 24 | $-7.2M | $35.0M | ||
| Q1 24 | $53.8M | $-11.0M |
| Q4 25 | — | $28.0M | ||
| Q3 25 | — | $64.8M | ||
| Q2 25 | — | $20.9M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | $6.9M | ||
| Q3 24 | $-35.5M | $34.2M | ||
| Q2 24 | $-7.3M | $33.5M | ||
| Q1 24 | $53.8M | $-12.1M |
| Q4 25 | — | 22.3% | ||
| Q3 25 | — | 60.7% | ||
| Q2 25 | — | 22.8% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | -68.7% | 37.3% | ||
| Q2 24 | -9.9% | 37.6% | ||
| Q1 24 | 39.0% | -15.3% |
| Q4 25 | 0.0% | 1.1% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.0% | 2.6% | ||
| Q1 25 | 0.0% | 1.9% | ||
| Q4 24 | 0.0% | 5.0% | ||
| Q3 24 | 0.3% | 1.2% | ||
| Q2 24 | 0.1% | 1.8% | ||
| Q1 24 | 0.1% | 1.4% |
| Q4 25 | — | 46.11× | ||
| Q3 25 | — | 3.27× | ||
| Q2 25 | — | 2.06× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | — | 2.16× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 9.78× | ||
| Q1 24 | 0.88× | -3.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
